Innovation Pharmaceuticals Inc.

OTCPK:IPIX Stock Report

Market Cap: US$52.9k

Innovation Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Leo Ehrlich

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure17.6yrs
CEO ownership1.3%
Management average tenureno data
Board average tenure8.8yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Leo Ehrlich's remuneration changed compared to Innovation Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$3m

Jun 30 2023US$516kUS$466k

-US$3m

Mar 31 2023n/an/a

-US$4m

Dec 31 2022n/an/a

-US$5m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022US$906kUS$466k

-US$7m

Mar 31 2022n/an/a

-US$8m

Dec 31 2021n/an/a

-US$10m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021US$516kUS$466k

-US$14m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020n/an/a

-US$10m

Sep 30 2020n/an/a

-US$6m

Jun 30 2020US$545kUS$466k

-US$7m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019n/an/a

-US$7m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019US$466kUS$466k

-US$9m

Mar 31 2019n/an/a

-US$12m

Dec 31 2018n/an/a

-US$13m

Sep 30 2018n/an/a

-US$14m

Jun 30 2018US$466kUS$466k

-US$16m

Compensation vs Market: Insufficient data to establish whether Leo's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Leo's compensation has been consistent with company performance over the past year.

CEO

Leo Ehrlich (66 yo)

17.6yrs

Tenure

US$515,850

Compensation

Mr. Leo Ehrlich, CPA serves as Chairman at Innovation Pharmaceuticals Inc. He has been the Chief Executive Officer and Chief Financial Officer of Innovation Pharmaceuticals Inc. (previously known as Cellce...

Board Members

NamePositionTenureCompensationOwnership
Leo Ehrlich
Chairman17.2yrsUS$515.85k1.34%
$ 708.6
William DeGrado
Scientific Advisor of Drug Discovery & Clinical Development4.4yrsno datano data
Stephen T. Sonis
Scientific Advisor of Oral Mucositis & Member of the Advisory Board8.8yrsno datano data
Francis Farraye
Scientific Advisor of Gastroenterology & Member of the Advisory Boardno datano datano data
Paul Ginsburg
Scientific Advisor of Intellectual Property13.8yrsno datano data
Gustavo Goldman
Scientific Advisor of Mycology & Fungal Diseases and Member of the Advisory Board1.8yrsno datano data

8.8yrs

Average Tenure

Experienced Board: IPIX's board of directors are considered experienced (8.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 10:38
End of Day Share Price 2025/01/03 00:00
Earnings2023/09/30
Annual Earnings2023/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Innovation Pharmaceuticals Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution